Skip to main content

Metastatic Process Does Not Select Cells for Metastatic Ability But Metastatic Cells Are Selected for by Drug Resistance. Implications for Tumor Progression

  • Chapter
New Concepts in Cancer

Abstract

It is now widely accepted that most tumors consist of subpopulations of cells that differ in many properties, including the ability to give rise to metastases (Fidler and Kripke, 1977). This cellular diversity is acquired during a tumor’s progression towards malignancy. The metastatic potential of a tumor is related to the frequency of tumor cells capable of accomplishing the totality of a very complex process, consisting of sequential steps. A metastatic cell is defined as a tumor cell that has proceeded through the entirety of the metastatic process, invading the surrounding normal tissues, surviving in the lymphatic or blood circulation, stopping and adhering to the capillary vessels and, finally, proliferating in an organ distant from the primary tumor and unrelated to its histological origin. Although it is not possible to exclude the role of stochastic events in the formation of metastases (Weiss, 1985), numerous observations lead one to assume that only a very limited subpopulation of tumor cells undergoes the metastatic process. Such cells could already be present when the tumor is first detectable clinically, suggesting that a subpopulation thus defined pre-exists in the tumor. They could also be constantly generated from non-metastatic tumor cells according to their mutation rate, as demonstrated by Ling et al. (1984). On the basis of these assumptions, the frequency of metastatic cells in a given tumor should be defined and stable, and the metastatic potential of the tumor should be constant.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Antoine, E., Pauwels-Vergely, C, Verrelle, P., Lascaux, V. and Poupon, M.F. (1988). In vivo emergence of a highly metastatic tumor cell line from a rat rhabdomyosarcoma after treatment with an alkylating agent. Br. J. Cancer, 57, 469–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cillo, C, Dick, J.E., Ling, V. and Hill, R.P. (1987). Generation of drug-resistant variants in metastatic B16 mouse melanoma cell lines. Cancer Res., 47, 2604–8.

    CAS  PubMed  Google Scholar 

  • Fidler, I.J. and Kripke, M.L. (1977). Metastasis results from preexisting variant cells within a malignant tumor. Science, 197, 893–5.

    Article  CAS  PubMed  Google Scholar 

  • Hamada, H. and Tsuruo, T. (1988). Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance. 170- to 180-kilodalton membrane glycoprotein is an ATPase. J. Biol. Chem., 263, 1454–8.

    CAS  PubMed  Google Scholar 

  • Hanna, N. (1985). The role of natural killer cells in the control of tumor growth and metastasis. Biochim. Biophys. Ada., 780, 213–24.

    CAS  Google Scholar 

  • Korach, S., Poupon, M.F., Duvillard, J.A. and Becker, M. (1986). Differential adhesiveness of rhabdomyosarcoma-derived cloned cell lines to vascular en-dothelial monolayers. Cancer Res. 46, 3624–39.

    CAS  PubMed  Google Scholar 

  • Kramer, N. and Ling, V. (1989). La résistance multidrogue aux medicaments anticanc6reux. Pour la Science, 139, 68–75.

    Google Scholar 

  • Ling, V., Chambers, A.F., Harris, J.F. and Hill, R.P. (1984). Dynamic heterogeneity and metastasis. J. Cell Physiol. (suppl.), 3, 99–103.

    Article  CAS  Google Scholar 

  • Mariani, B.D. and Schimke, R.T. (1984). Gene amplification in a single cell cycle in Chinese hamster ovary cells. J. Biol. Chem., 259, 1901–10.

    CAS  PubMed  Google Scholar 

  • Nolibe, D. and Poupon, M.F. (1986). Enhancement of pulmonary metastases induced by decreased lung natural killer cell activity. J. Nad Cancer Inst., 71, 99–103.

    Google Scholar 

  • Pauwels-Vergely, C. and Poupon, M.F. (1987). Immunogenic capacity of tum-variants isolated from a rat rhabdomyosarcoma Br. J. Cancer, 56, 7–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pot-Deprun, J., Poupon, M.F., Sweeney, F.L. and Chouroulinkov, I. (1983). Growth metastasis, immunogenicity and chromosome content of a nickel-induced rhabdomyosarcoma and subsequent cloned cell lines in rats. Natl Cancer Inst., 71, 1241–5.

    CAS  Google Scholar 

  • Poupon, M.-F. et al. (1984). Cancer Treatment Reports, 68 (5), May, 749–58.

    Google Scholar 

  • Sager, R., Gadi, I.K., Stephens, L. and Grabowy, C.T. (1985). Gene amplification: an example of accelerated evolution in tumorigenic cells. Proc. NatlAcad. Sci. USA, 82, 7015–19.

    Article  CAS  Google Scholar 

  • Stark, G.R. and Wahl, G.M. (1984). Gene amplification. Ann. Rev. Biochem., 53, 447–91.

    Article  CAS  PubMed  Google Scholar 

  • Sweeney, F.L. et al. (1982). Cancer Res., 42, Sept., 3776–82.

    Google Scholar 

  • Ueda, K., Cornwell, M.M., Gotesman, M.M., Pastan, I., Roninson, I.B., Ling, V. and Riordan, J.R. (1986). The mdrl gene, responsible for multidrug resistance, codes for P-glycoprotein. Biochem. Biophys. Res. Common., 141, 956–61.

    Article  CAS  Google Scholar 

  • Young, S.D., Marshall, R.S. and Hill, R.P. (1988). Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc. NatlAcad. Sci. USA, 85, 9533–7.

    Article  CAS  Google Scholar 

  • Weiss, L. (ed.) (1985). Principles of Metastasis. Academic Press, New York.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Copyright information

© 1990 Macmillan Publishers Limited

About this chapter

Cite this chapter

Poupon, MF. et al. (1990). Metastatic Process Does Not Select Cells for Metastatic Ability But Metastatic Cells Are Selected for by Drug Resistance. Implications for Tumor Progression. In: Etievant, C., Cros, J., Rustum, Y.M. (eds) New Concepts in Cancer. Palgrave, London. https://doi.org/10.1007/978-1-349-10671-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-349-10671-4_9

  • Publisher Name: Palgrave, London

  • Print ISBN: 978-1-349-10673-8

  • Online ISBN: 978-1-349-10671-4

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics